Clinical Trial
RET RP 01 - NCT01543906 Completed
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal DominantMutation in Retinal Pigment Epithelial 65 Protein (RPE65).
Disease
Disease type
Retinitis Pigmentosa
Orphan drug recognition
No
Patient type
Adult
Children
Inclusion / Exclusion
Funding
industry
Members involved
Main investigators
ERN EYE member investigating site
HCP : Principal investigators
ERN-EYE Ireland Consortium (EEIC), Dublin, Ireland
Adress
Eccles St, Dublin 7
D07 R2WY Dublin
Ireland